MyCode

Tokyo, Japan Founded: 2014 • Age: 12 yrs
Provides reliable genetic testing services for personalized health insights.

About MyCode

MyCode is a Healthcare company based in Tokyo (Japan) founded in 2014. It provides reliable genetic testing services for personalized health insights. It operates on a B2C model. Its focus areas include Biotechnology, Genetic Testing and Diagnostic Services. Its competitors include Miltel, Cranebio and Theranostic Research Institute; 1 of its 3 listed competitors has raised funding.

Company details

MyCode, based in Tokyo, focuses on providing healthcare solutions, advancing biotech innovations, genetic testing, and diagnostic services. Provides reliable genetic testing services for personalized health insights. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.

  • Headquarters Tokyo, Japan
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website mycode.jp
  • Social X Facebook
Operational Areas

Competitors of MyCode

MyCode has 3 listed competitors in our database, 1 of them funded. They include Miltel, Cranebio and Theranostic Research Institute.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
mirtel.co.jp2012Hiroshima, Japan$5.28M
Telomere tests for aging detection and cellular senescence are provided.
crane-bio.com2021Minato, Japan
Self-service genetic test kits for women's health are developed.
theranos-inst.com2006Nagoya, Japan
Prognostic genetic testing for cardiovascular diseases is provided.
Premium access

Detailed competitors of MyCode

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of MyCode

Websites that share an audience with MyCode (mycode.jp).

Similar websites

Websites whose visitors overlap most with MyCode. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
dnafit.com
32%
9.8KView details
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about MyCode

MyCode was founded in 2014.

MyCode is headquartered in Tokyo, Japan. It is registered at Tokyo, Tokyo, Japan.

MyCode, based in Tokyo, focuses on providing healthcare solutions, advancing biotech innovations, genetic testing, and diagnostic services. Provides reliable genetic testing services for personalized health insights. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.

MyCode's top competitors include Miltel, Cranebio and Theranostic Research Institute.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available